DANCANN PHARMA A/S
CVR number: 39426005
Rugvænget 5, 6823 Ansager
INFO@DANCANN.COM
tel: 69160393
https://dancann.com
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 874.00 | 5 708.00 | 6 073.00 | ||
| Manufacturing for enterprise's own use | 1 481.00 | 1 080.00 | |||
| Other operating income | 41.00 | 279.00 | |||
| Purchases during the financial year | -3 334.00 | -4 108.00 | |||
| External services | -9 566.00 | -6 767.00 | |||
| Gross profit | 527.00 | -2 835.00 | -6 494.00 | -5 670.00 | -3 443.00 |
| Employee benefit expenses | -8 517.00 | -9 451.00 | |||
| Total depreciation | -2 231.00 | -47 221.00 | |||
| EBIT | 527.00 | -2 835.00 | -6 494.00 | -16 418.00 | -60 115.00 |
| Other financial income | 1 191.00 | 204.00 | |||
| Other financial expenses | -3 023.00 | -2 328.00 | |||
| Pre-tax profit | - 500.00 | -4 255.00 | -11 750.00 | -18 250.00 | -62 239.00 |
| Income taxes | 2 186.00 | -21.00 | |||
| Net earnings | - 500.00 | -4 255.00 | -11 750.00 | -16 064.00 | -62 260.00 |
Assets (kDKK)
| 2022 | 2023 | |
|---|---|---|
| Development expenditure | 35 736.00 | |
| Intangible rights | 821.00 | |
| Goodwill | 11 221.00 | 9 945.00 |
| Intangible assets total | 47 778.00 | 9 945.00 |
| Buildings | 5 936.00 | 3 839.00 |
| Advance payments and construction in progress | 3 345.00 | 97.00 |
| Tangible assets total | 9 281.00 | 3 936.00 |
| Other receivables | 322.00 | 322.00 |
| Investments total | 322.00 | 322.00 |
| Long term receivables total | ||
| Finished products/goods | 339.00 | |
| Advance payments | 3.00 | 341.00 |
| Inventories total | 342.00 | 341.00 |
| Current trade debtors | 1 611.00 | |
| Prepayments and accrued income | 474.00 | 440.00 |
| Current other receivables | 1 538.00 | 298.00 |
| Current deferred tax assets | 1 598.00 | 106.00 |
| Short term receivables total | 5 221.00 | 844.00 |
| Cash and bank deposits | 10 751.00 | 2 006.00 |
| Cash and cash equivalents | 10 751.00 | 2 006.00 |
| Balance sheet total (assets) | 73 695.00 | 17 394.00 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 2 438.00 | 5 311.00 | |||
| Other reserves | 27 874.00 | ||||
| Retained earnings | 500.00 | 4 255.00 | 11 750.00 | 48 545.00 | 66 455.00 |
| Profit of the financial year | - 500.00 | -4 255.00 | -11 750.00 | -16 064.00 | -62 260.00 |
| Shareholders equity total | 62 793.00 | 9 506.00 | |||
| Non-current liabilities total | |||||
| Current loans from credit institutions | 7 557.00 | 5 913.00 | |||
| Current trade creditors | 2 749.00 | 1 093.00 | |||
| Other non-interest bearing current liabilities | 596.00 | 882.00 | |||
| Current liabilities total | 10 902.00 | 7 888.00 | |||
| Balance sheet total (liabilities) | 73 695.00 | 17 394.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.